Astera Labs (NASDAQ:ALAB) Shares Down 9.5% – Time to Sell?

Astera Labs, Inc. (NASDAQ:ALAB)’s stock price was down 9.5% during trading on Tuesday . The company traded as low as $395.54 and last traded at $397.93. 3,250,581 shares traded hands during trading, a decline of 43% from the average daily volume of 5,683,385 shares. The stock had previously closed at $439.66.

Wall Street Analyst Weigh In

A number of equities analysts recently weighed in on ALAB shares. Evercore reaffirmed an “outperform” rating and issued a $297.00 price target on shares of Astera Labs in a report on Tuesday, May 19th. Royal Bank Of Canada raised their price objective on Astera Labs from $250.00 to $270.00 and gave the company an “outperform” rating in a report on Wednesday, May 6th. Northland Securities cut Astera Labs from an “outperform” rating to a “market perform” rating in a research report on Tuesday, May 26th. Citigroup lowered Astera Labs from a “buy” rating to a “market perform” rating in a research report on Tuesday, May 26th. Finally, Jefferies Financial Group reissued a “buy” rating and issued a $270.00 price target on shares of Astera Labs in a research note on Wednesday, May 6th. Twelve analysts have rated the stock with a Buy rating and eleven have issued a Hold rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $244.75.

Astera Labs Stock Performance

The stock has a market capitalization of $68.21 billion, a PE ratio of 268.87, a price-to-earnings-growth ratio of 5.52 and a beta of 3.95. The stock’s 50 day moving average is $270.63 and its two-hundred day moving average is $189.58.

Astera Labs (NASDAQ:ALAB) last posted its quarterly earnings data on Tuesday, May 5th. The company reported $0.61 EPS for the quarter, topping the consensus estimate of $0.54 by $0.07. Astera Labs had a return on equity of 18.49% and a net margin of 26.72%.The company had revenue of $308.36 million during the quarter, compared to analyst estimates of $292.19 million. During the same period in the previous year, the business earned $0.33 EPS. Astera Labs’s quarterly revenue was up 93.5% on a year-over-year basis. Astera Labs has set its Q2 2026 guidance at 0.680-0.700 EPS. Equities research analysts expect that Astera Labs, Inc. will post 1.84 EPS for the current fiscal year.

Insider Activity

In other Astera Labs news, Director Stefan A. Dyckerhoff sold 3,505 shares of the firm’s stock in a transaction on Wednesday, June 3rd. The stock was sold at an average price of $364.35, for a total value of $1,277,046.75. Following the transaction, the director owned 60,134 shares in the company, valued at approximately $21,909,822.90. This trade represents a 5.51% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Jack R. Lazar sold 10,000 shares of Astera Labs stock in a transaction on Thursday, June 4th. The stock was sold at an average price of $355.17, for a total transaction of $3,551,700.00. Following the sale, the director directly owned 75,688 shares in the company, valued at approximately $26,882,106.96. This trade represents a 11.67% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 2,161,256 shares of company stock valued at $459,844,296 in the last three months. Company insiders own 10.40% of the company’s stock.

Institutional Trading of Astera Labs

Hedge funds have recently bought and sold shares of the business. Eurizon Capital SGR S.p.A. purchased a new position in Astera Labs during the fourth quarter worth about $18,708,000. Nordea Investment Management AB purchased a new stake in shares of Astera Labs in the 4th quarter valued at approximately $2,028,000. Geneva Partners LLC acquired a new position in shares of Astera Labs in the 3rd quarter worth approximately $1,876,000. Swedbank AB boosted its position in shares of Astera Labs by 76.8% during the 4th quarter. Swedbank AB now owns 78,140 shares of the company’s stock worth $12,999,000 after purchasing an additional 33,940 shares during the period. Finally, Numerai GP LLC boosted its position in shares of Astera Labs by 153.1% during the 3rd quarter. Numerai GP LLC now owns 13,212 shares of the company’s stock worth $2,587,000 after purchasing an additional 7,992 shares during the period. Institutional investors and hedge funds own 60.47% of the company’s stock.

Astera Labs Company Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.